Form 4: Harmony Biosciences Executive Dierks Sells Shares Under 10b5-1 Plan
SEC Form 4
Jeffrey Dierks, Chief Commercial Officer of Harmony Biosciences Holdings, Inc., sold 11,979 shares of common stock on March 15, 2024, under a pre-arranged 10b5-1 trading plan.
Summary
- On March 15, 2024, Jeffrey Dierks, the Chief Commercial Officer of Harmony Biosciences Holdings, Inc., executed transactions involving the company's common stock.
- Dierks acquired 11,979 shares through the exercise of stock options at a price of $8.22 per share.
- Simultaneously, Dierks sold 11,979 shares at a weighted average price of $32, with individual sales ranging from $32.00 to $32.06.
- These transactions were conducted under a pre-arranged Rule 10b5-1 trading plan.
- Following these transactions, Dierks directly owns 0 shares of common stock and 4,869 derivative securities.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it's a standard disclosure of stock transactions by an executive. The transactions themselves don't necessarily indicate a positive or negative outlook for the company.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions. It provides transparency into the trading activities of company executives, which is important for investors to monitor.
Stakeholder Impact
- The sale of shares by an executive could be perceived negatively by some shareholders, although the existence of a 10b5-1 plan mitigates concerns about opportunistic trading.
Key Dates
| Date | Description |
|---|---|
| 10/01/2019 | Start date for vesting of one stock option grant in five equal annual installments. |
| 03/01/2021 | Start date for vesting of another stock option grant in five equal annual installments. |
| 03/15/2024 | Date of stock option exercise and sale of shares. |
| 03/18/2024 | Date of Form 4 filing. |
| 10/01/2029 | Expiration date of one stock option grant. |
| 03/04/2030 | Expiration date of another stock option grant. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.